Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,658 | 34,620 | 204 | N/A | N/A |
| TOTAL | $80,655 | $34,828 | $227 | $N/A | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 27 | 595 | 66 | 0 | 0 |
| TOTAL | $27 | $595 | $66 | $N/A | $N/A |
| Total Assets | $80,682 | $35,423 | $293 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 903 | 778 | 306 | 0 | 0 |
| Accrued Expenses | 2,772 | 847 | 75 | N/A | N/A |
| TOTAL | $3,675 | $1,625 | $582 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $1,500 | $1,500 | $1,500 | $N/A | $N/A |
| Total Liabilities | $5,175 | $3,125 | $2,082 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,153 | 15,153 | N/A | N/A | N/A |
| Common Shares | 15 | 0 | 0 | N/A | N/A |
| Retained earnings | -66,916 | -59,155 | -54,478 | N/A | N/A |
| Other shareholders' equity | 0 | 91,453 | 50,279 | 0 | 0 |
| TOTAL | $75,508 | $32,298 | $-1,788 | $N/A | $N/A |
| Total Liabilities And Equity | $80,682 | $35,423 | $293 | $0 | $0 |